Skip to content
Open in App
Otsuka logo

Otsuka

web2

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, an...

Symbol · 4578
Company profile

About

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipment, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, quasi-drugs, household products, and packaging materials and electronic parts. In addition, it offers IT solutions; adhesive tapes; flaky titanate and compounds; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; rental of space and office businesses; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. The company was founded in 1921 and is headquartered in Chiyoda, Japan.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

Progress

Roadmap

Otsuka signs agreement to acquire Transcend Therapeutics

KEY STEP

Otsuka Pharmaceutical entered into an agreement to acquire Transcend Therapeutics through Otsuka America. The deal calls for $700 million at closing and up to $525 million in contingent payments linked to future sales milestones. Completion was expected in the second quarter of 2026, subject to customary conditions and required procedures.

Roadmap reference

Otsuka reports positive VOYXACT Phase 3 kidney function data and begins rolling sBLA

KEY STEP

Otsuka reported a prespecified interim analysis from the Phase 3 VISIONARY study showing preservation of kidney function over twelve months in adults with primary IgA nephropathy treated with VOYXACT. The company also announced that it had begun a rolling supplemental Biologics License Application submission to the US FDA seeking traditional approval, with the final submission intended to incorporate the study's twenty four month eGFR endpoint data.

Roadmap reference
People

Company team

MM

Mayo Mita

Independent Outside Director

Company leadership profile.

JS

Jiro Seguchi

Independent Outside Director

Company leadership profile.

IO

Ichiro Otsuka

Chairman

Company leadership profile.

MI

Makoto Inoue

President, CEO & Representative Director

Company leadership profile.

TH

Tatsuo Higuchi

Chairman Emeritus, Executive Director & Advisor

Company leadership profile.

YM

Yuko Makino

CFO & Executive Director

Company leadership profile.

NT

Noriko Tojo

Executive Director

Company leadership profile.

YM

Yoshiro Matsuo

Executive Deputy President & Representative Director

Company leadership profile.

MK

Masayuki Kobayashi

Executive Director

Company leadership profile.

ST

Shuichi Takagi

Executive Director

Company leadership profile.

YM

Yukio Matsutani

Independent Outside Director

Company leadership profile.

YA

Yoshihisa Aoki

Independent Outside Director

Company leadership profile.

TK

Tatsuaki Kitachi

Independent Outside Director

Company leadership profile.

HS

Hiroshi Sugawara

Outside Auditor & Supervisory Board Member

Company leadership profile.

YT

Yozo Toba

Standing Audit & Supervisory Board Member

Company leadership profile.

ST

Sachie Tsuji

Outside Auditor & Supervisory Board Member

Company leadership profile.

KO

Kanako Osawa

Outside Auditor & Supervisory Board Member

Company leadership profile.

Expert coverage

1 expert evaluated Otsuka.

Orbitrum research

Experts evaluating Otsuka

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment